Publication | Closed Access

CXCR3 blockade combined with cyclosporine A alleviates acute graft-versus-host disease by inhibiting alloreactive donor T cell responses in a murine model

InflammationTransplantationAutoimmune DiseaseCxcr3 BlockadeImmunosuppressive TherapyMurine ModelImmunologyCyclosporine AAutoimmunityGraft SurvivalCell TransplantationImmunosuppressionImmunotherapyMedicineCell BiologyGraft Rejection